A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish
Open Access
- 1 January 2006
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 45 (1) , 28-37
- https://doi.org/10.1080/02841860500417536
Abstract
The quality of life questionnaire EORTC C30 with the head and neck specific module H&N35 has been validated in many languages and cultural settings, but the H&N35 module has not been formally translated to and validated in Danish. This validation was the purpose of the current study. In a cross sectional study 116 of 120 (97%) recurrence free head and neck cancer patients returned a valid questionnaire. The patients were attending follow up after radical radiotherapy (n=83), surgery (n=33) for cancer of the larynx (n=44), pharynx (n=34) or oral cavity (n=38). The previously described psychometric properties of the questionnaire were confirmed with the Danish translation. Nevertheless, there were some foreseeable problems with heavily skewed endpoints. Several scales of the questionnaire were sensitive to patient, tumour and treatment related factors: Good performance, high age, male gender, laryngeal cancer, low tumour stage and surgery correlated with a low score on the symptom scales or high score on the function scales. Symptom intensity increased with time since therapy in patients who had surgery and decreased in the irradiated patients. In conclusion, the current validation study confirmed the psychometric properties of the EORTC H&N35 questionnaire. The questionnaire detected correlations between clinical factors (performance status, gender, age, stage, site, time since therapy, treatment) and a large number of QoL factors. EORTC H&N35 in conjunction with EORTC C30 is a valid and informative tool in assessing quality of life, also in Danish head and neck cancer patients.Keywords
This publication has 24 references indexed in Scilit:
- Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal studyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- The eortc QLQ‐C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patientsPsycho‐Oncology, 2002
- A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patientsEuropean Journal Of Cancer, 2000
- Quality of LifePublished by Wiley ,2000
- Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35Journal of Clinical Oncology, 1999
- The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.Journal of Clinical Oncology, 1996
- Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal CancerActa Oncologica, 1994
- Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer PatientsActa Oncologica, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer PatientsActa Oncologica, 1992